AMP2026_Logo

About

About

ORGANIZING COMMITTEE

The Organizing Committee of AMP Europe 2026

amp-laura-tafe

Chair

Laura J. Tafe, MD
Lebanon, New Hampshire, USA
Dartmouth Hitchcock Medical Center

Mafouz_Rami

Vice-Chair

Rami Mafouz, MD, MPH
Beirut, Lebanon
American University of Beirut Medical Center

amp-reddi-h

Committee - Genetics

Honey Reddi, PhD
Sussex, Wisconsin, USA
Belay Diagnostics

amp-Iorgulescu-j

Committee - HemePath

Julian Bryan Iorgulescu, MD
Houston, Texas, USA
University of Texas MD Anderson Cancer Center

amp-bard-j

Committee - Infectious Diseases

Jennifer Bard, PhD
Los Angeles, California, USA
Children Hospital Los Angeles

c-bell

Committee - Informatics

Robert C. Bell, MD
Ann Arbor, Michigan, USA
University of Michigan

amp-yemelyanova-a

Committee - Solid Tumors

Anna Yemelyanova , MD
New York, New York, USA
Weill Cornell Medical College

amp-fernanda-sabato

Committee - Tech Topics

M. Fernanda Sabato
Richmond, Virginia, USA
VCU Health

IMPORTANT DATES

ABSTRACT SUBMISSIONS OPEN

December 10, 2025

REGISTRATION OPENS

January 14, 2026

ABSTRACT SUBMISSION DEADLINE

February 20, 2026

EARLY BIRD REGISTRATION DEADLINE

March 25, 2026

REGULAR REGISTRATION FROM

March 26, 2026

MORE ABOUT AMP

USEFUL INFORMATION

UEMS Credits

An application will be made to the UEMS EACCME® for CME accreditation of this event.

Find out more about UEMS EACCME accreditation: https://www.uems.eu/uems-eaccme

EACCME credits recognition for USA attendees

The UEMS-EACCME® has had an agreement of mutual recognition of credits with the American Medical Association (AMA) for Live Educational Events and for E-Learning Materials since the year 2000. The agreement was renewed in 2022 for another 4 years.

The issue of territoriality is very important; both organizations are fully responsible for the activities taking place or organized within their remit. The UEMS-EACCME® is the central body for accrediting events in Europe and the AMA is the central body for recognition of CME credits in the USA.

E-learning activities need to be certified for credit by the process in place where the CME provider is based, i.e. AMA PRA Category 1 Credit™ for U.S. CME providers and ECMEC® credit for organizations in countries that are represented by the UEMS.

Learn more here: https://eaccme.uems.eu/international-collaborations

Currency

The legal tender in Tallinn is the Euro which is pegged to the US dollar at a rate of about 1 Euro to 1,18 USD, although exchange rates may fluctuate.

Tipping in Tallinn is not mandatory, but a gratuity of around 5–10% is customary in restaurants for good service. In taxis, for example, it is common to round up to the nearest Euro.

Liability Disclaimer

The organizers cannot be held liable for any hindrance or disruption of the congress proceedings arising from political, social or economic events or any other unforeseen incidents beyond their control. The organizers will accept no liability for any personal injuries or illness sustained or for loss or damage of property belonging to congress participants, either during or as a result of the congress or during all events. Registration of a participant entails acceptance of these conditions.

Name badge

The name badge will be the official meeting document and should be worn at all times in order to gain entry to the meeting rooms and the exhibition hall. Admission to the conference will not be allowed without a badge identification. In case of loss or forgotten badges, an administration fee of 20 EUR will be charged at the hospitality desk on site.

Photography, Audio, Video and Mobile Phone policy

Audio, photo and video recordings by any device is strictly prohibited during all Oral and Poster Presentations, unless prior permission is obtained from the congress organizer. The use of mobile phones is strictly prohibited during scientific sessions. Mobile phones must be switched off while attending the sessions.

Electricity

The standard voltage in Estonia is 230 V with a frequency of 50 Hz.

For participants from countries with plugs other than the two round-pin Europlug (types C or F), it is advised to bring an adapter, as wall outlets in Estonia typically accommodate plugs with two round pins and grounding

Congress Language

The official language of the congress will be English. Simultaneous translation will not be provided.

Congress documents

Registration fee for participants covers admission to scientific sessions and satellite symposia, admission to the exhibition, lunch and coffee breaks and a get-together.

Helpful Phone Numbers

Emergency services (police, fire, ambulance): 112

Insurance

The congress organizers do not accept any liability for damages and/or loss of any kind which may be incurred by the congress participants or by any persons accompanying them. Delegates participate in all events at their risk.

Participants are advised to take out insurance against loss, accidents or damage that could occur during the congress. Verbal agreements will not be binding unless they are confirmed in writing.

Laura J. Tafe

Laura Tafe is a Professor of Pathology and Laboratory Medicine at Dartmouth Hitchcock Medical Center in Lebanon, NH where she is the Director of the Laboratory for Clinical Genomics and Advanced Technology (CGAT). She works as a molecular and anatomic pathologist with expertise in pulmonary and GYN pathology and directs the Dartmouth Cancer Center’s Molecular Tumor Board. Dr. Tafe has most recently served as the AMP Past-President and as a member of the Professional Relations Committee.

Rami Mafouz, MD, MPH

Rami Mahfouz is currently a Tenured Professor and Head of Division of Clinical Pathology in the Department of Pathology and Laboratory Medicine at the American University of Beirut Medical Center and the Director of the Histocompatibility and Molecular Diagnostics Laboratory, Director of the Residency Training Program, and Chairman of the Biomedical Institutional Review Board. He is a member of several international and professional societies including the College of American Pathologists (CAP), the American Society of Histocompatibility and Immunogenetics (ASHI) and the American Association of Molecular Pathologists (AMP) where he is serving as the Chair of the International Affairs Committee.

Honey Reddi

Dr. Reddi currently serves as Chief Laboratory Officer for Belay Diagnostics. Prior to her current position, Dr. Reddi was a Professor and Chief of the Division of Clinical Genomics at the Medical College of Wisconsin. With a background in biotechnology and specialized training in Clinical Molecular Genetics from the Mayo Clinic, where she also led a translational research program on thyroid cancer, Dr. Reddi had been recognized for her outstanding contributions to the field. She received the 2023 Outstanding Graduate Educator award for her contributions as faculty and course director to the MS in Precision Medicine at MCW and the 2018 “Women of Innovation Award” for her leadership in bioscience and technology from the Connecticut Technology Council. Dr. Reddi is passionate about mentoring the next generation of laboratory geneticists.

Julian Bryan Iorgulescu

Dr. Bryan is an assistant professor and director of genomic clinical decision support in the Molecular Diagnostics Laboratory at MD Anderson Cancer Center.

Jennifer Bard

Jennifer Dien Bard, PhD, D(ABMM), FIDSA, FAAM is a Professor of Pathology with Clinical Scholar designation in the Department of Pathology, Keck School of Medicine, University of Southern California. She is the Chief of Clinical Operations and Director of the Clinical Microbiology and Virology Laboratories in the Department of Pathology and Laboratory Medicine at Children’s Hospital Los Angeles.

Robert C. Bell

Dr. Robert Bell, MD is a Clinical Assistant Professor of Pathology and Section Head of Informatics for the Division of Genetics & Genomics. With expertise in hematopathology, molecular genetic pathology, bioinformatics, and clinical informatics, he leads efforts to integrate data science and computational tools into diagnostic medicine. Dr. Bell’s work focuses on advancing genomic data interpretation, informatics infrastructure, and precision diagnostics to improve patient care and translational research.

Anna Yemelyanova

Molecular and Surgical pathologist at Weill Cornell Medical College, New York, New York

M. Fernanda Sabato

I am leading the molecular diagnostics field, specializing in genetics and genomics, oncology, precision medicine, and infectious diseases, particularly in hepatitis and transplantation using state of art technologies such as NGS. In this capacity, I collaborate on the development, validation and implementation of innovative molecular diagnostic tests, ensuring their seamless integration into clinical care. By creating, enhancing, and managing quality control (QC) and quality assurance (QA) programs, alongside driving process improvements and strategies to optimize operational efficiency, I manage and lead a molecular high-complexity CLIA/CAP laboratory in an academic medical center.
Soon!